About ComplyRx
Pharmaceutical
intelligence,
connected.
Understanding a pharmaceutical programme means looking across trial registries, company announcements, research and disclosures. Each source answers part of the question.
ComplyRx brings those records and relationships together. Explore the wider landscape, choose what you want to follow and review relevant changes with their supporting sources close by.
A connected view of
the wider landscape.
A trial is part of a larger story. It belongs to a development programme, involves companies and sits alongside other evidence. ComplyRx connects these records so you can move from an individual development to the relationships around it.
Start with the programme
Explore trial records alongside drug and company information. Names, aliases and identifiers help connect records that refer to the same asset, giving you a more coherent starting point for research.
See how the pieces relate
Follow the relationships between trials, drugs and companies, with licence and mechanism context where available. These connections help place an individual record within a wider programme or competitive landscape.
Read around a development
Research, company announcements and filings add context to the underlying records. Keep the supporting material close as you investigate a development and decide what it means for your work.
Follow the landscape
that matters to you.
Your work may begin with a company portfolio, a particular drug or a question about a disease. A watch gives that focus a place in ComplyRx, bringing relevant trials and developments into a scope you can return to.
Choose the companies, drugs, diseases or classes you want to follow. The scope reflects your interests, whether you are examining one programme or building a view across an area of research.
Follow a sponsor and its portfolio, including the programmes and assets connected to it.
Focus on an individual asset using its name, brand or development code.
Explore trials within an indication and follow activity relevant to that area.
Look across drug classes and mechanisms to understand related programmes.
Understand
what changed.
A changed date, a revised endpoint or a new company announcement can raise a different question. ComplyRx brings relevant changes into view so you can review the detail and return to the underlying record.
Trial progress
Review changes to milestones, recruitment status and enrolment to understand how a study record has moved on.
Study design
Examine changes to endpoints and study design, then revisit the trial record for the detail behind the update.
Company activity
Read relevant announcements and SEC disclosures alongside the trials, drugs and companies they relate to.
Research and licence information provide connected context. They are distinct from the trial changes and company communications followed by a watch.
Different roles.
Different questions.
The same development can matter for different reasons. ComplyRx gives people working across life sciences a connected starting point for their own questions.
Commercial and strategy
Explore company portfolios, follow competing programmes and investigate the relationships around an asset. Build context for portfolio planning, competitive intelligence and business development.
Medical and research
Follow trial programmes and the evidence around them. Examine changes to study records and connect the underlying trial with related research and company information.
Analysts and advisers
Bring developments and their sources together when preparing research, briefings or advice. Move between the wider landscape and individual records as your assessment takes shape.
Keep the evidence close.
Useful intelligence should let you examine the evidence behind it. ComplyRx keeps source material connected to records and developments, so you can revisit the original information as you form your own assessment.
A registry update describes a change to a record. A company announcement provides the company’s account. Reading them in context helps you distinguish what a source reports from the conclusions you draw.
Less time finding.
More time
understanding.
Bringing records, relationships and changes together reduces the need to reconstruct the same context each time. Return to the landscape you follow, investigate what has moved and keep the evidence within reach.
Start with the companies, drugs, diseases or classes that matter to your work. Build from there as your questions develop.
Start tracking